Bharat Biotech intranasal vaccine to be available as booster dose for those over 18 in next few weeks

The DCGI (Drugs Controller General of India) gave its go-ahead for the completion of its vaccine trials and the formal announcement about the intranasal vaccine is likely to be made in the next few days, according to sources. ​​​​The nasal vaccine, BBV154 or Incovacc, had last month received a green signal from the Central Drugs Standard Control Organisation (CDSCO) under restricted use in an emergency situation for the 18+ population in India as heterologous booster doses.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/CNyzxo1
via IFTTT